|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 91 No. 12 (June 15), 1998:
pp. 4803-4809
Characterization of Plasmodium falciparum-Infected
Erythrocyte and P-Selectin Interaction Under Flow Conditions
By
May Ho,
Tineke Schollaardt,
Xiaofei Niu,
Sornchai Looareesuwan,
Kamala D. Patel, and
Paul Kubes
From the Department of Microbiology and Infectious Diseases,
University of Calgary, Calgary, Alberta, Canada; the
Immunology Research Group, University of Calgary, Calgary,
Alberta, Canada; and the Faculty of Tropical Medicine, Mahidol
University, Bangkok, Thailand.
 |
ABSTRACT |
Plasmodium falciparum-infected erythrocytes
(IRBC) roll on the adhesion molecule P-selectin in vitro
under flow conditions that approximate the shear stress in capillary
and postcapillary venules in which cytoadherence occurs in vivo. The
pathological significance of this adhesive interaction is currently
unknown. In this study, we further investigated the molecular
interactions between IRBC and P-selectin by using a laminar flow system
that allowed for the direct visualization of IRBC-substratum
interactions. The results showed that the IRBC-P-selectin interaction
was Ca2+-dependent and involved the lectin domain of
P-selectin and a sialic acid residue on IRBC. The sialylated P-selectin
ligand was trypsin-sensitive, which suggests that it could be part of the parasite antigen PfEMP1 that interacts with CD36 and intercellular adhesion molecule-1 (ICAM-1), but different from a
trypsin-resistant IRBC ligand that adheres selectively to chondroitin
sulfate A. Studies on the rolling and adhesion of IRBC on activated
platelets that express both CD36 and P-selectin showed that inhibition
of rolling on P-selectin reduced the adhesion of some clinical parasite isolates to CD36, whereas other parasite isolates appeared to interact
directly with CD36. Thus, cytoadherence under physiological flow
conditions may be mediated by multiple IRBC ligands that interact with
different adhesion molecules in a cooperative fashion. These findings
underscore the complexity of the interactions betweeen IRBC and
vascular endothelium.
 |
INTRODUCTION |
PLASMODIUM FALCIPARUM malaria is a major
cause of death in the tropics. The pathology is due mainly to the
sequestration of parasitized erythrocytes (IRBC) in the
microcirculation leading to alterations in blood flow, metabolic
dysfunction, and local toxicity.1 In the effort to develop
therapeutic strategies that would inhibit or reverse sequestration,
considerable interest has been focused on the mechanisms of the
underlying cytoadherent process whereby IRBC adhere to capillary and
postcapillary venular endothelium. In studies using a parallel plate
flow chamber in which IRBC were infused under shear conditions over
mouse L-cells transfected with individual adhesion molecules or
immobilized receptor proteins, we and others demonstrated previously
that IRBC rolled and adhered to CD36.2,3 The interaction
with intercellular adhesion molecule-1 (ICAM-1) was mainly
one of rolling. In addition, we showed that IRBC rolled on P-selectin
and vascular adhesion molecule-1 (VCAM-1). Furthermore,
although adhesion of IRBC to CD36 could occur without prior rolling on
another adhesion molecule, rolling on ICAM-1 enhanced subsequent
adhesion of some parasite isolates to CD36 on C32 melanoma cells that
constitutively express both molecules. Clearly, IRBC can use different
adhesion molecules in a cooperative fashion to make contact with and
adhere to vascular endotheium.
The initial capture and rolling of leukocytes on endothelium, a
prerequisite for adhesion, are mediated by the selectin family of
adhesion molecules.4 Although IRBC also roll on P-selectin, whether this adhesion molecule serves a similar role in the adhesive interactions between IRBC and endothelium remains unknown. Therefore, the first objective of the present study was to characterize the molecular interactions of IRBC and P-selectin using clinical parasite isolates and immobilized recombinant soluble P-selectin. Second, we
examined if IRBC rolling on P-selectin enhanced adhesion to CD36
expressed on platelet monolayers. We showed that IRBC-P-selectin interaction involved the lectin domain of P-selectin and a
trypsin-sensitive sialylated ligand on IRBC. Furthermore, IRBC rolling
on P-selectin of some clinical parasite isolates enhanced their
subsequent adhesion to CD36, whereas other parasite isolates interacted
with CD36 independently of P-selectin. These results underscore the
complexity of the interaction between IRBC and vascular endothelium
under physiological shear stress.
 |
MATERIALS AND METHODS |
Parasites.
Clinical isolates of P falciparum obtained from acutely
infected patients admitted to the Hospital for Tropical Diseases
(Bangkok, Thailand) were studied. The study protocol was approved by
the ethics committee of the Faculty of Tropical Medicine, Mahidol University (Bangkok, Thailand). P falciparum malaria was
diagnosed by the demonstration of asexual parasites in peripheral blood smears. Fifteen milliliters of blood was taken on admission before antimalarial therapy was initiated. Washed erythrocytes were
cryopreserved in glycerolyte5 and stored in liquid nitrogen
after the removal of the buffy coat and platelets. They were
transported to Calgary on dry ice.
A fresh aliquot of cryopreserved IRBC was used for each of the
following experiments. Thawed parasites were grown for 24 to 36 hours
in RPMI 1640 medium (GIBCO BRL Life Technologies, Gaithersburg, MD)
supplemented with 25 mmol/L HEPES (Sigma Co, St Louis, MO), 100 U/mL of
penicillin and 100 g/mL streptomycin (Sigma), 2 mmol/L glutamine
(Sigma), and 10% normal AB serum from a normal Thai donor. IRBC were
harvested for laminar flow studies when the parasites had reached the
late trophozoite/early schizont stage as judged by light microscopy.
IRBC suspensions of 1% hematocrit in RPMI and 1% AB serum were
prepared. To validate the use of cryopreserved parasites, experiments
performed using fresh and frozen IRBC from a parasite isolate obtained
in Calgary showed that they interacted equally with immobilized
P-selectin protein and platelet monolayers.
Soluble P-selectin.
Recombinant soluble P-selectin was kindly provided by Dr R.P. McEver
(University of Oklahoma, Oklahoma City, OK).6 One hundred
microliters of a solution at 5 µg/mL Hanks' balanced salt solution
(HBSS; GIBCO BRL) was immobilized on 25 × 50 mm
glass coverslips (Fisher Scientific Co, Nepean, Ontario, Canada) for 2 hours at 37°C and then overnight at 4°C. The coverslips were blocked with 1% bovine serum albumin (BSA) in HBSS for 2 hours at 37°C before use. Coverslips coated with BSA alone were
prepared as controls.
Platelet monolayers.
Platelets from normal donors were harvested from citrated whole blood
by centrifugation. They were resuspended in HBSS at 2 × 108/mL. Platelet monolayers were prepared on 25 × 50 mm glass coverslips that had been precoated with type 1 rat tail
collagen (Collaborative Biomedical Products, Bedford, MA) at 37°C
for 1 hour. One milliliter of platelet suspension was added to each
coverslip after the collagen had been gently pipetted off and was
incubated at 37°C for 1 hour. Unattached platelets were removed by
gently rinsing the monolayer three times in HBSS. Platelet monolayers
were fixed in 1% buffered formalin (Sigma) at room temperature for 1 hour and stored at 4°C for a maximum of 2 weeks. IRBC interacted
equally with freshly immobilized platelets and fixed platelet
monolayers.
CD36 transfectant.
A stable transfectant of mouse LA9 cells (CCL 1.4, HPRT APRT ; ATCC, Rockville, MD)
permanently expressing CD36 was constructed as described.2
Transfected cells were maintained in Dulbecco's modified Eagle's
medium (DMEM; GIBCO BRL) supplemented with 4 mmol/L
glutamine, 100 U/mL of penicillin, 100 µg/mL of streptomycin, and
10% fetal calf serum (FCS; GIBCO BRL). Monolayers of
CD36 transfectants were prepared by plating 1 mL of cells at 5 × 105/mL on 25 × 50 mm glass coverslips in 60 × 100 mm Petri dishes. The cells were allowed to adhere for 2 hours at
37°C, 5% CO2, after which 6 mL of supplemented medium
was added to each dish. After 40 to 48 hours of culture, confluent
monolayers were rinsed in HBSS and used immediately in laminar flow
studies.
Antibodies.
The following specific monoclonal antibodies (MoAbs) were used in the
studies: OKM5, an anti-CD36 MoAb known to inhibit both rolling and
adhesion of IRBC on CD362 (kind gift of Ortho Diagnostics System, Raritan, NJ); G1, an anti-P-selectin MoAb that inhibits neutrophil rolling; and S12, an anti-P-selectin MoAb that binds but
does not inhibit neutrophil-P-selectin interaction.7 Both anti-P-selectin MoAb were kind gifts of Dr R.P. McEver. A polyclonal anti-P-selectin antibody was raised in a NZW female rabbit by immunizing with an intramuscular injection of 50 µg/mL of purified human P-selectin in Freund's complete adjuvant, followed in 4 weeks by
a second subcutaneous injection in incomplete Freund's adjuvant. The
rabbit was terminally bled two weeks after the second dose. The titer
of the antiserum against P-selectin was found to be greater than
1:20,000 by enzyme-linked immunosorbent assay (ELISA), but it did not
react with purified CD36 at 1:100 dilution. A mouse IgG1 (Becton
Dickinson Immunocytometry Systems, San Jose, CA) and normal rabbit
serum (NRS) were used as controls.
In experiments in which the inhibitory effect of antibodies was
studied, the P-selectin spots and platelet monolayers were preincubated
with antibody at 37°C for 30 minutes. The same concentration of
antibody was maintained in the perfusate throughout the experiment.
Parallel plate flow chamber system.
A laminar flow system to study the dynamic interaction between IRBC and
various cellular substrata was established as previously described.8 Briefly, cells or recombinant protein on glass coverslips were assembled in a parallel plate flow chamber of 220-µm
gap thickness in which a uniform wall shear stress was generated. The
flow chamber was mounted on the stage of an inverted phase contrast
microscope that is kept at 37°C by a temperature regulator. A
suspension of IRBC in RPMI 1640, pH 7.2, and 1% AB serum was drawn
through the flow chamber at varying rates with a Harvard infusion pump
attached to the outlet. At this concentration of IRBC, attached IRBC
and their motion were clearly observed with phase contrast objectives
(200×) and quantitated by analysis of videotaped images.
Experiments were conducted at 1 dyne/cm2, which we have
found previously to be optimal for IRBC interactions with both
P-selectin and CD36.2
Effect of Ca2+ on IRBC rolling.
Adhesive interactions of leukocytes and all selectins are
Ca2+-dependent.9 To study the effect of
Ca2+ on IRBC rolling on P-selectin, soluble P-selectin was
immobilized in Ca2+ and Mg2+ free HBSS to which
1.8 mmol/L MgCl2 and 1 mmol/L EGTA were added (Ca2+-free HBSS). The spots were blocked with 1% BSA in
the same buffer. Before IRBC infusion into the parallel plate flow
chamber, the flow system was flushed with Ca2+-free HBSS
for 5 minutes. IRBC were washed three times in Ca2+-free
HBSS and resuspended at 1% hematocrit in the same buffer.
Effect of fucoidin.
Sulfated polysaccharides interfere with leukocyte rolling by binding to
the lectin domain of selectins.10 To determine if IRBC
interacts with the lectin domain of P-selectin, we examined the effect
of fucoidin, a homopolymer of fucose, on IRBC rolling. Fucoidin (Sigma)
at 4 to 100 µg/mL HBSS was prepared just before use. For each
concentration tested, fucoidin was infused for 5 minutes over the
immobilized P-selectin before an IRBC suspension containing the same
concentration of fucoidin. The number of rolling IRBC in the presence
or absence of fucoidin were compared. Dextran (Sigma) and chondroitin
sulfate A (Sigma), two other carbohydrates with no known interactions
with P-selectin, were used as controls.
Role of sialic acid residue in IRBC rolling.
To determine if IRBC rolling on P-selectin is mediated by a sialic acid
residue, a suspension of IRBC at 5% hematocrit was incubated with
neuraminidase from Arthrobacter ureafaciens
(Calbiochem-Nevabiochem Corp, La Jolla, CA) at 1 U/mL of 0.15 mol/L
NaCl, 10 mmol/L HEPES, 5 mmol/L CaCl2, pH 6.5, for 1 hour
at 37°C. A similar IRBC suspension was incubated in the same volume
of buffer alone as control. At the end of the incubation, IRBC were
washed three times in 10 mL of RPMI and resuspended at 1% hematocrit
in RPMI + 1% AB serum.
In other experiments, 2.5 mmol/L of the tetrasaccharide sialyl
Lewisx was added to the IRBC suspension after baseline
rolling was established. The sugar was a kind gift of Dr Robert D. Larsen (Glycomed Inc, Alameda, CA). The number of rolling cells before
and after the addition of the sugar were compared.
Effect of proteases on IRBC rolling.
To determine whether the P-selectin ligand on IRBC is associated with a
protein, IRBC at 5% hematocrit in RPMI were incubated with 100 µg/mL
of TPCK-treated trypsin (Sigma) or TLCK-treated chymotrypsin (Sigma) at
37°C for 30 minutes. The trypsin reaction was terminated by the
addition of 1 mg/mL of soybean trypsin inhibitor (Sigma). Trypsin
inhibitor alone was added to control IRBC. The chymotrypsin reaction
was stopped by the addition of 10% human serum. The enzyme-treated
cells were washed twice with RPMI before use in flow experiments.
Rolling and adhesion of IRBC on activated platelets.
Immobilized activated platelets express both CD363 and
P-selectin,11 allowing us to use this substratum as a dual
adhesion molecule expression system. To confirm that the platelet
monolayers used in these studies expressed functional P-selectin,
neutrophils were perfused over the platelets. Neutrophil rolling
was observed and was completely inhibited by the MoAb G1 (10 µg/mL)
and the polyclonal anti-P-selectin antibody (1:100).
To determine the respective roles of CD36 and P-selectin in IRBC
rolling and adhesion when both molecules are present on the same cell
surface, IRBC were infused over platelet monolayers in the presence of
the CD36-specific MoAb OKM5 at 10 µg/mL or the polyclonal
anti-P-selectin at 1:100 dilution. Mouse IgG1 and NRS at the same
concentrations were used as controls.
Experimental analysis and statistics.
Rolling and adhesion of IRBC on immobilized receptor protein and
platelet monolayers were determined for each minute of perfusion. A
rolling cell was defined as one that was in contact with the substratum
but was not stationary. These cells could be seen to roll end over end
across the substratum surface. The flux of rolling IRBC on soluble
P-selectin was expressed as the number of cells that rolled past a
fixed line on the monitor screen during a 1-minute interval. IRBC
rolling velocity was calculated from the time required for a given IRBC
to travel 100 µm along the chamber, expressed as the mean velocity ± SD for 50 cells counted in consecutive frames. On platelet
monolayers, an IRBC was considered adherent if it remained stationary
for at least 10 seconds. The total number of rolling and adherent cells
were counted for a 10-minute period and the results were expressed as
the number of rolling or adherent IRBC per minute per square millimeter
of surface area. All values were expressed as the mean ± SEM or
mean ± SD, as indicated. The significance of correlation was
determined by Spearman's rank sum test. A P value of less than
.05 was considered statistically significant.
 |
RESULTS |
IRBC rolling on P-selectin.
Ten randomly selected clinical P falciparum isolates were
studied. The parasitemia ranged from 2.1% to 9.5%. All of the
isolates tethered and rolled on immobilized soluble P-selectin. The
rolling interaction was specific, because it was completely inhibited by a polyclonal antibody raised against soluble human P-selectin at
1:200 dilution, but not by the same concentration of NRS
(Fig 1). However, the anti-P-selectin MoAb
G1, which completely inhibits neutrophil rolling at 10 µg/mL, had no
effect on IRBC rolling. A nonblocking MoAb S12 at the same
concentration also had no effect (data not shown).

View larger version (23K):
[in this window]
[in a new window]
| Fig 1.
Rolling of IRBC on immobilized soluble P-selectin in the
presence of NRS, G1, a MoAb that inhibits neutrophil rolling on
P-selectin, and an anti-P-selectin polyclonal Ab. Immobilized
P-selectin was preincubated with each of the Ab at the concentrations
indicated at 37°C for 30 minutes. The same concentration of Ab was
maintained in the perfusate. Values represent the mean number of
rolling cells ± SEM of 10 clinical P falciparum isolates
studied.
|
|
The mean rolling velocities of the IRBC from the 10 parasite isolates
showed considerable variability (Table 1).
For a given isolate, the degree of rolling, as indicated by the number
of rolling IRBC after equilibrium was reached, correlated positively with parasitemia (r = .621, P < .05) and inversely
with rolling velocity (r = .830, P < .01).
View this table:
[in this window]
[in a new window]
|
Table 1.
Rolling Velocity of IRBC From 10 Clinical P
falciparum Isolates on Immobilized Soluble P-Selectin (5 µg/mL)
at 1 dyne/cm2
|
|
Ca2+ dependency.
The lectin domain of selectins binds Ca2+ and undergoes
conformational changes before interacting with its
ligands.12 The role of Ca2+ in IRBC rolling on
P-selectin was studied with 5 parasite isolates. IRBC rolling was
inhibited by 70% in the absence of Ca2+ in all cases
(Fig 2), consistent with the requirement
for Ca2+ in the interaction of P-selectin with other
ligands.

View larger version (22K):
[in this window]
[in a new window]
| Fig 2.
Requirement of Ca2+ for IRBC rolling on
immobilized soluble P-selectin. IRBC suspended in Ca2+
free HBSS were infused over soluble P-selectin immobilized in the same
buffer. Results represent the mean number of rolling cells ± SEM for
5 clinical P falciparum isolates studied.
|
|
Effect of fucoidin on IRBC rolling on P-selectin.
Fucoidin is a fucosylated sugar that binds to the lectin domain of
P-selectin and is known to interfere with the interaction between
P-selectin and its natural ligand PSGL-1 on neutrophils. We observed
that fucoidin inhibited the interaction between IRBC from all 5 parasite isolates tested and immobilized soluble P-selectin in a
dose-dependent fashion (Fig 3). Two other
carbohydrates, namely dextran and chondroitin sulfate A, at 100 µg/mL
had no effect on IRBC rolling.

View larger version (55K):
[in this window]
[in a new window]
| Fig 3.
Effect of fucoidin on IRBC rolling on immobilized soluble
P-selectin. IRBC suspended in increasing concentrations of fucoidin, a
sulfated homopolymer of fucose, in HBSS were infused over immobilized P-selectin. Dextran and chondroitin sulfate A, two other carbohydrates with no known interaction with P-selectin, were used as controls. Values represent the mean number of rolling cells ± SEM for 5 clinical P falciparum isolates studied.
|
|
Effect of proteases on IRBC rolling on P-selectin.
To further delineate the biochemical nature of the P-selectin ligand on
IRBC, IRBC from 5 parasite isolates were treated with trypsin and
chymotrypsin. Enzyme treatment for 30 minutes at 37°C markedly
inhibited the interaction of all 5 parasite isolates with P-selectin
(Fig 4). The enzyme treatment also
inhibited both rolling and adhesion of IRBC on CD36 transfectants (data
not shown).

View larger version (30K):
[in this window]
[in a new window]
| Fig 4.
Effect of neuraminidase and proteases on IRBC rolling on
immobilized soluble P-selectin. A 5% suspension of IRBC was treated with 1 U/mL of neuraminidase from Arthrobacter ureafaciens for 1 hour at 37°C. Control IRBC were incubated in buffer alone (mock neuraminidase). IRBC were also treated with 100 µg/mL of TPCK-treated trypsin and TLCK-treated chymotrypsin at 37°C for 30 minutes. Values represent the mean number of rolling cells ± SEM for 5 clinical P falciparum isolates studied.
|
|
Role of sialic acid residue in IRBC rolling on P-selectin.
P-selectin is known to bind to carbohydrates or sialoglycoproteins. To
determine if a sialylated residue on IRBC is involved in the
interaction with P-selectin, IRBC were treated with neuraminidase and
then infused over immobilized P-selectin. The results are shown in Fig
4. There was complete inhibition of rolling on immobilized P-selectin
for neuraminidase-treated IRBC from all isolates tested, suggesting the
expression of a sialic acid moiety on IRBC. The involvement of a sialic
acid residue was confirmed by the inhibition of IRBC rolling on
P-selectin by sialyl Lewisx
(Fig 5).

View larger version (19K):
[in this window]
[in a new window]
| Fig 5.
Effect of the tetrasaccharide sialyl Lewisx
(sLex) on IRBC rolling on immobilized soluble P-selectin.
IRBC were infused over immobilized P-selectin until equilibrium was
reached. sLex (2.5 mmol/L) was then added to the IRBC
suspension. Values represent the mean number of rolling cells ± SEM
for 3 parasite isolates studied.
|
|
Rolling and adhesion of IRBC on platelets.
IRBC from all six clinical isolates tested rolled and adhered to
activated platelets that expressed both CD36 and P-selectin. The two
types of adhesive interactions were sequential, in that greater than
90% of adherent cells rolled for varying distances before arresting on
the cell surface. Only an occasional IRBC tethered and adhered
immediately at that position.
Receptor-specific antibodies were used to determine the respective
roles of CD36 and P-selectin on IRBC rolling and adhesion on activated
platelets. The inhibition of IRBC rolling on platelets by OKM5 was
variable (57% to 77%; mean ± SD, 69% ± 7.3%). In contrast, adhesion to platelet monolayers was inhibited by greater than 95% in
all cases. The same concentration of OKM5 completely inhibited all
rolling and adhesive interactions between IRBC and CD36
transfectants.2
IRBC from three of six parasite isolates studied showed reduced rolling
and subsequent adhesion on immobilized platelets in the presence of an
anti-P-selectin antibody. The antibody had no effect on the adhesive
interactions between platelets and IRBC from three other isolates. The
results of duplicate experiments with each of the isolates are
summarized in Table 2. The inhibitory effect of the anti-P-selectin antibody was receptor specific, because
it had no effect on the rolling and adhesion of the same isolates to
CD36 transfectants at 1:100 dilution (data not shown).
 |
DISCUSSION |
We have shown previously that P falciparum-infected
erythrocytes roll on P-selectin under flow conditions at shear rates
that approximate those encountered by IRBC in capillaries and
post-capillary venules in vivo.2 In this study, we extended
the observation in demonstrating that IRBC interact with the lectin
domain of P-selectin, because rolling is Ca2+-dependent and
inhibitable by fucoidin. Fucoidin and other sulfated glycoconjugates
are known to interfere with sporozoite invasion of hepatocytes,
merozoite reinvasion of erythrocytes, and rosetting of uninfected
erythrocytes around IRBC.13 Our finding of IRBC rolling on
P-selectin adds to the growing list of glycoconjugate-lectin interactions that are important in cell adhesion at different stages of
parasite development.
The exact site of IRBC interaction with P-selectin has not been
determined. It does not appear to involve the same epitope as for
PSGL-1, the natural ligand for P-selectin. A similar situation has been
shown for the interaction between IRBC and ICAM-1 in which the epitope
recognized by IRBC in the first Ig-domain of the molecule is distinct
from the binding sites of either LFA-1 or rhinovirus.14 The
lack of inhibition by the MoAb S12 shows that IRBC are not interacting
directly with the fifth complement regulatory protein-like short
consensus repeat unit of P-selectin.15
On the surface of the infected erythrocyte, we showed that IRBC rolling
on P-selectin requires a sialic acid residue by demonstrating that the
process is neuraminidase sensitive and inhibitable by sialyl
Lewisx to the same extent as it did neutrophil rolling on
immobilized P-selectin (Kubes et al, unpublished data).
Neuraminidase treatment of IRBC actually increases their adhesion to
CD36 in static adhesion assays,16,17 confirming that the
enzyme treatment per se does not adversely affect ligand-receptor
interaction. The sensitivity of the interaction to proteases indicate
that the P-selectin ligand is likely to be located on a glycoprotein
and not a glycolipid associated with the cell surface. Whether P
falciparum erythrocyte membrane protein 1 (PfEMP1), the
parasite-derived variant cytoadherent ligand that has already been
shown to interact with CD36,18 ICAM-1,18
thrombospondin,18 and complement-receptor 1 (CR1),19 is involved in the IRBC-P-selectin interaction
remains to be determined. Clinical parasite isolates may be made up of
parasite subpopulations each expressing a different cytoadherent
ligand, or individual IRBC can express multiple ligands that interact
with different adhesion molecules on activated endothelium. IRBC
expressing at least two ligands with different sensitivity to trypsin
have been shown previously for laboratory-adapted parasite lines
selected on CHO cells, one of which is specific for chondroitin sulfate A.20 Further work is necessary to establish whether the
IRBC ligand for P-selectin is of parasite origin or a red blood cell antigen that has been exposed by conformational changes induced by the
presence of an intracellular parasite.
In this study, activated platelets were used as a model for CD36 and
P-selectin expression on a single cell. Other adhesion molecules or
adhesive proteins expressed on activated platelets might have
contributed to the observed IRBC-platelet interaction. In particular,
the adhesive glycoprotein thrombospondin (TSP) has been shown to
mediate cytoadherence of IRBC to rat endothelium under flow
conditions.21 However, because ligand-receptor interactions are likely to be species-specific, it is difficult to assess if the
findings in an ex vivo animal model are directly relevant to the human
infection. Cooke et al3 have shown that both IRBC rolling
and adhesion on purified TSP is essentially absent under flow
conditions in vitro. The data in this report confirmed that IRBC
adhesion to activated platelets is almost exclusively via CD36, whereas
approximately 30% of rolling IRBC may be interacting with other
molecules.
IRBC rolled and then adhered on activated platelets. Inasmuch as these
adhesive interactions appeared to be sequential steps in IRBC
cytoadherence under flow conditions, any reduction in rolling would
likely adversely affect adhesion. We showed that an antibody that
inhibited IRBC rolling on P-selectin partially inhibited the rolling
and, as a result, adhesion of IRBC from some clinical parasite isolates
on platelet monolayers. The same antibody had no effect on the rolling
and adhesion of the same isolates on CD36 transfectants. This
observation suggests that rolling on P-selectin may enhance subsequent
adhesion to CD36 and is in keeping with our hypothesis that
cytoadherence of IRBC on vascular endothelium under physiological shear
stress is a cooperative process involving different parasite ligands
and endothelial receptors.2 The cooperation or synergy
between selectins in the recruitment of leukocytes is well
documented.22 The rolling interactions with molecules such
as P-selectin in this study and ICAM-12 appear to
facilitate adhesion to CD36, even if they individually are of much
lower avidity than that required to allow attachment. On the other
hand, some parasite isolates could interact with CD36 exclusively on
platelet monolayers. These findings highlight the diversity of the
adhesive properties of clinical P falciparum isolates relative
to the much more homogeneous adhesive mechanisms used by leukocytes.
The observation is not entirely unexpected, because the expression of
the various domains of PfEMP1 that interact with different adhesive
molecules is highly variable among parasite isolates.17
The clinical significance of IRBC rolling on P-selectin remains to be
determined. P-selectin may be important in mediating capture and fast
rolling of IRBC followed by slower rolling and attachment on CD36 early
in the infective process as P-selectin is readily mobilized from
intracellular stores in postcapillary venular
endothelium.23 As the infection progresses, additional adhesion molecules are likely to become involved as they are
upregulated both directly by parasite products24 and
through the proinflammatory cytokines that they induce.25
The cooperative interaction of IRBC with a number of different adhesion
molecules is particularly important in view of the fact that, whereas
the expression of selectins and integrins may be readily modulated by
cytokines and pharmacological agents,26 CD36 expression on
microvascular endothelium is not affected by these
mediators.27 In other words, the degree of cytoadherence of
P falciparum on vascular endothelium may be regulated at the
level of the expression of adhesion molecules such as P-selectin and
ICAM-1 rather than that of CD36. Therapeutic intervention with
receptor-specific peptides or soluble ligands may inhibit or reverse
cytoadherence in the same manner that they reduce leukocyte recruitment
in experimental models of acute inflammation.28,29
 |
FOOTNOTES |
Submitted November 25, 1997;
accepted February 10, 1998.
Supported by the UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases, the Medical Research Council of Canada,
the Alberta Heritage Foundation for Medical Research, Alberta, Canada,
and the Wellcome-Mahidol University, Oxford Tropical Medicine Research
Programme funded by the Wellcome Trust of Great Britain.
Address reprint requests to May Ho, MD, Department of
Microbiology & Infectious Diseases, Health Sciences Centre, 3330 Hospital Dr NW, Calgary, Alberta, Canada T2N 4N1.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" is accordance with 18 U.S.C. section 1734 solely to indicate this fact.
 |
ACKNOWLEDGMENT |
The authors are grateful to the nurses and patients of the Hospital for
Tropical Diseases (Bangkok, Thailand) for their cooperation and Dr J.G.
Geng (Upjohn Laboratories, Kalamazoo, MI) for technical advice.
 |
REFERENCES |
1.
White NJ,
Ho M:
The pathophysiology of malaria.
Adv Parasitol
31:83,
1992[Medline]
[Order article via Infotrieve]
2.
Udomsangpetch R,
Reinhardt PH,
Schollaardt T,
Elliott JF,
Kubes P,
Ho M:
Promiscuity of clinial Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions.
J Immunol
158:4358,
1997[Abstract]
3.
Cooke BM,
Berendt AR,
Craig AG,
MacGregor J:
Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: Separate roles for ICAM-1, CD36 and thrombospondin.
Br J Haematol
87:162,
1994[Medline]
[Order article via Infotrieve]
4.
Lawrence MB,
Springer TA:
Leukocyte roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins.
Cell
85:859,
1991
5.
Merryman HT,
Hornblower M:
A method for freezing and washing red blood cells using a high glycerol concentration.
Transfusion
12:145,
1972[Medline]
[Order article via Infotrieve]
6.
Ushiyama S,
Laue TM,
Moore KL,
Erikson HP,
McEver RP:
Structural and functional characterisation of monomeric soluble P-selectin and comparison with membrane P-selectin.
J Biol Chem
268:15229,
1993[Abstract/Free Full Text]
7.
Geng JG,
Bevilacqua MP,
Moore KL,
McIntyre TM,
Prescott SM,
Kim JM,
Bliss GA,
Zimmerman GA,
McEver RP:
Rapid neutrophil adhesion to activated endothelium mediated by GMP-140.
Nature
343:757,
1990[Medline]
[Order article via Infotrieve]
8.
Lawrence MB,
McIntire LV,
Eskin SG:
Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion.
Blood
70:1284,
1987[Abstract/Free Full Text]
9.
Geng JG,
Heavner GA,
McEver RP:
Lectin domain peptides from selectins interact with both cell surface ligands and Ca2+ ions.
J Biol Chem
267:19846,
1992[Abstract/Free Full Text]
10.
Nelson RM,
Dolich S,
Aruffo A,
Cecconi O,
Bevilacqua MP:
Higher-affinity oligosaccharide ligands for E-selectin.
J Clin Invest
91:1157,
1993
11.
Buttrum SM,
Hutton R,
Nash GB:
Selectin-mediated rolling of neutrophils on immobilized platelets.
Blood
82:1165,
1993[Abstract/Free Full Text]
12.
Geng JG,
Moore KL,
Johnson AE,
McEver RP:
Neutrophil recognition requires a Ca2+-induced conformational change in the lectin domain of GMP-140.
J Biol Chem
266:22313,
1991[Abstract/Free Full Text]
13.
Rowe A,
Berendt AR,
Marsh K,
Newbold CI:
Plasmodium falciparum: A family of sulphated glycoconjugates disrupts erythrocyte rosettes.
Exp Parasitol
79:506,
1994[Medline]
[Order article via Infotrieve]
14.
Ockenhouse CF,
Betageri R,
Springer TA,
Staunton DE:
Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus.
Cell
68:63,
1992[Medline]
[Order article via Infotrieve]
15.
Patel KD,
Nollert MU,
McEver RP:
P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils.
J Cell Biol
131:1893,
1995[Abstract/Free Full Text]
16.
David PH,
Hommel M,
Miller LH,
Udeinya IJ,
Oligino LD:
Parasite sequestration in Plasmodium falciparum malaria: Spleen and antibody modulation of cytoadherence of infected erythrocytes.
Proc Natl Acad Sci USA
80:5075,
1983[Abstract/Free Full Text]
17.
Sherman IW,
Valdez E:
In vitro cytoadherence of Plasmodium falciparum-infected erythrocytes to melanoma cells: Factors affecting adhesion.
Parasitology
98:359,
1989
18.
Baruch DI,
Gormley JA,
Ma C,
Howard RJ,
Pasloske BL:
Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.
Proc Natl Acad Sci USA
93:3497,
1996[Abstract/Free Full Text]
19.
Rowe JA,
Moulds JM,
Newbold CI,
Miller LH:
P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1.
Nature
388:292,
1997[Medline]
[Order article via Infotrieve]
20.
Chaiyaroj SC,
Coppel RL,
Novakovic S,
Brown GV:
Multiple ligands for cytoadherence can be present simultaneously on the surface of Plasmodium falciparum-infected erythrocytes.
Proc Natl Acad Sci USA
91:10805,
1994[Abstract/Free Full Text]
21.
Rock EP,
Roth EF,
Rojas-Corona RR,
Sherwood JA,
Nagel RL,
Howard RJ,
Kaul DK:
Thrombospondin mediates the cytoadherence of Plasmodium falciparum-infected red cells to vascular endothelium in shear flow conditions.
Blood
71:71,
1988[Abstract/Free Full Text]
22.
Ley K,
Tedder TF:
Leukocyte interactions with vascular endothelium. New insight into selectin-mediated attachment and rolling.
J Immunol
155:525,
1995[Abstract]
23.
Kubes P,
Kanwar S:
Histamine induces leukocyte rolling in post-capillary venules: A P-selectin-mediated event.
J Immunol
152:3577,
1994
24.
Schofield L,
Novakovic S,
Gerold P,
Schwarz RT,
McConville MJ,
Tachado SJ:
Glycosylphosphatidylinositol toxin of Plasmodium upregulates intercellular adhesion molecule-1, vascular adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction.
J Immunol
156:1886,
1996[Abstract]
25.
Schofield L,
Hackett F:
Signal transduction in host cells by glycosylphosphatidylinositol toxin of malaria parasites.
J Exp Med
177:145,
1993[Abstract/Free Full Text]
26.
Kansas GS:
Selectins and their ligands: Current concepts and controversies.
Blood
88:3259,
1996[Free Full Text]
27.
Petzelbauer P,
Bender JR,
Wilson J,
Pober JS:
Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture.
J Immunol
151:5062,
1993[Abstract]
28.
Norman KE,
Scheding C,
Kunkel EJ,
Heavner GA,
Ley K:
Peptides derived from the lectin domain of selectin adhesion molecules inhibit leukocyte rolling in vivo.
Microcirculation
3:29,
1996[Medline]
[Order article via Infotrieve]
29.
Takada M,
Nadeau KC,
Shaw GD,
Marquette KA,
Tilney NL:
The cytokine-adhesion molecule cascade in ischemia-reperfusion injury of the rat kidney.
J Clin Invest
99:2682,
1997[Medline]
[Order article via Infotrieve]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Combes, A. R. Rosenkranz, M. Redard, G. Pizzolato, H. Lepidi, D. Vestweber, T. N. Mayadas, and G. E. Grau
Pathogenic Role of P-Selectin in Experimental Cerebral Malaria: Importance of the Endothelial Compartment
Am. J. Pathol.,
March 1, 2004;
164(3):
781 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sun, W.-L. Chang, J. Li, S. M. Berney, D. Kimpel, and H. C. van der Heyde
Inhibition of Platelet Adherence to Brain Microvasculature Protects against Severe Plasmodium berghei Malaria
Infect. Immun.,
November 1, 2003;
71(11):
6553 - 6561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Serirom, W. H. Raharjo, K. Chotivanich, S. Loareesuwan, P. Kubes, and M. Ho
Anti-Adhesive Effect of Nitric Oxide on Plasmodium falciparum Cytoadherence under Flow
Am. J. Pathol.,
May 1, 2003;
162(5):
1651 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-L. Chang, J. Li, G. Sun, H.-L. Chen, R. D. Specian, S. M. Berney, D. N. Granger, and H. C. van der Heyde
P-Selectin Contributes to Severe Experimental Malaria but Is Not Required for Leukocyte Adhesion to Brain Microvasculature
Infect. Immun.,
April 1, 2003;
71(4):
1911 - 1918.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. G. Yipp, D. I. Baruch, C. Brady, A. G. Murray, S. Looareesuwan, P. Kubes, and M. Ho
Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo
Blood,
January 1, 2003;
101(1):
331 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Senczuk, J. C. Reeder, M. M. Kosmala, and M. Ho
Plasmodium falciparum erythrocyte membrane protein 1 functions as a ligand for P-selectin
Blood,
November 15, 2001;
98(10):
3132 - 3135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lou, R. Lucas, and G. E. Grau
Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans
Clin. Microbiol. Rev.,
October 1, 2001;
14(4):
810 - 820.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. M. Matsui, L. Borsig, S. D. Rosen, M. Yaghmai, A. Varki, and S. H. Embury
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
Blood,
September 15, 2001;
98(6):
1955 - 1962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gamain, J. D. Smith, L. H. Miller, and D. I. Baruch
Modifications in the CD36 binding domain of the Plasmodium falciparum variant antigen are responsible for the inability of chondroitin sulfate A adherent parasites to bind CD36
Blood,
May 15, 2001;
97(10):
3268 - 3274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ho, M. J. Hickey, A. G. Murray, G. Andonegui, and P. Kubes
Visualization of Plasmodium falciparum-Endothelium Interactions in Human Microvasculature: Mimicry of Leukocyte Recruitment
J. Exp. Med.,
October 16, 2000;
192(8):
1205 - 1212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Yipp, S. Anand, T. Schollaardt, K. D. Patel, S. Looareesuwan, and M. Ho
Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow
Blood,
September 15, 2000;
96(6):
2292 - 2298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. O'Connor, J. A. Long, and D. R. Allred
Cytoadherence of Babesia bovis-Infected Erythrocytes to Bovine Brain Capillary Endothelial Cells Provides an In Vitro Model for Sequestration
Infect. Immun.,
August 1, 1999;
67(8):
3921 - 3928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ho and N. J. White
Molecular mechanisms of cytoadherence in malaria
Am J Physiol Cell Physiol,
June 1, 1999;
276(6):
C1231 - C1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Reeder, A. F. Cowman, K. M. Davern, J. G. Beeson, J. K. Thompson, S. J. Rogerson, and G. V. Brown
The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1
PNAS,
April 27, 1999;
96(9):
5198 - 5202.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|